Skip to content
Disclosery

Eagle Health Investments LP

Follow

13F filer, CIK 1842545, Greenwich, CT

Eagle Health Investments LP reported $405,166,711 across 21 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-12. Its ten largest share positions make up 74.32% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-25-003039

Period
2025-06-30
Reported value
$405M
Holdings
21
Top 10 weight
74.32%
New
4
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
UNHnew+60,888$19M
BBIOnew+259,300$11.2M
GHnew+212,000$11M
SRRKnew+269,400$9.54M
ARGXadded+2,440$1.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
INSPexited-81,121-$12.9M
ASNDexited-56,500-$8.81M
EXASreduced-164,900-$8.76M
NTRAreduced-43,800-$7.4M
DXCMreduced-83,100-$7.25M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001172661-25-003039, largest first. % of portfolio is the value over $405,166,711, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 513,700 shares; 2024Q4: 513,700 shares; 2025Q1: 443,300 shares; 2025Q2: 428,600 shares 428,600$43.1M10.65%-14,700Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 74,990 shares; 2024Q4: 74,990 shares; 2025Q1: 74,990 shares; 2025Q2: 77,430 shares 77,430$42.7M10.53%+2,440Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 431,314 shares; 2024Q4: 339,764 shares; 2025Q1: 279,764 shares; 2025Q2: 235,964 shares 235,964$39.9M9.84%-43,800Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 387,354 shares; 2024Q4: 343,361 shares; 2025Q1: 343,361 shares; 2025Q2: 343,361 shares 343,361$32.8M8.09%0Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 130,790 shares; 2024Q4: 209,190 shares; 2025Q1: 209,190 shares; 2025Q2: 202,790 shares 202,790$29.5M7.28%-6,400Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 128,600 shares; 2024Q4: 155,000 shares; 2025Q1: 225,100 shares; 2025Q2: 217,200 shares 217,200$27.3M6.74%-7,900Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 451,492 shares; 2024Q4: 274,551 shares; 2025Q1: 356,921 shares; 2025Q2: 273,821 shares 273,821$23.9M5.9%-83,100Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 561,700 shares; 2024Q4: 627,600 shares; 2025Q1: 627,600 shares; 2025Q2: 627,600 shares 627,600$22.8M5.63%0Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 419,212 shares; 2024Q4: 419,212 shares; 2025Q1: 382,612 shares; 2025Q2: 366,812 shares 366,812$20.2M4.98%-15,800Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,700 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,888 shares 60,888$19M4.69%newTimeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 233,089 shares; 2024Q4: 233,089 shares; 2025Q1: 299,089 shares; 2025Q2: 299,089 shares 299,089$17.2M4.25%0Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 76,256 shares; 2024Q4: 76,256 shares; 2025Q1: 65,656 shares; 2025Q2: 46,086 shares 46,086$15M3.71%-19,570Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 226,400 shares; 2025Q2: 226,400 shares 226,400$12.1M2.98%0Timeline
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 544,200 shares; 2024Q4: not reported; 2025Q1: 388,650 shares; 2025Q2: 223,750 shares 223,750$11.9M2.93%-164,900Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 259,300 shares 259,300$11.2M2.76%newTimeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 212,000 shares 212,000$11M2.72%newTimeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 330,830 shares; 2024Q4: 330,830 shares; 2025Q1: 330,830 shares; 2025Q2: 330,830 shares 330,830$11M2.72%0Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 269,400 shares 269,400$9.54M2.36%newTimeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,390 shares; 2024Q4: 4,390 shares; 2025Q1: 4,390 shares; 2025Q2: 4,390 shares 4,390$2.39M0.59%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 46,300 shares; 2024Q4: 46,300 shares; 2025Q1: 46,300 shares; 2025Q2: 46,300 shares 46,300$1.45M0.36%0Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 240,500 shares; 2025Q2: 240,500 shares 240,500$1.21M0.3%0Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INSPINSPIRE MED SYS INC81,121$12.9Mshares
ASNDASCENDIS PHARMA A/S56,500$8.81Mshares
TMDXTRANSMEDICS GROUP INC100,661$6.77Mshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-25-003039 base2025-08-12acceptance time not in the bulk data set